Amgen‘s (NASDAQ:AMGN) biosimilar drug portfolio will be studied in clinical trials in alliance with clinical research organization PRA.PRA has entered into a strategic partnership with Amgen to do work on a series of phase 3 studies to develop biosimilar drugs. Biosimilars are follow-on biologic drugs that are cheaper than very expensive biologic drugs. No financial [...]

Immunotherapy company Argos Therapeutics, which last month withdrew plans for a $65 million initial public offering, has now secured a $25 million round of financing to start phase 3 clinical trials on its novel kidney cancer treatment.Forbion Capital led the series D round, joined by fellow existing investors TVM Capital, Lumira Capital, Intersouth Partners, Caisse [...]

We’d like to think that the health care delivery system puts patient needs first and ensures that patients and families have the right information in mind before making momentous treatment decisions. Unfortunately, despite a great deal of awareness raising and education, this still is not the case. Radiation oncologists are publicizing a new study that [...]

In prostate cancer treatment, newer might not necessarily be better.University of North Carolina at Chapel Hill research has found that intensity modulated radiation therapy, or IMRT, is as effective and produces fewer side effects than the newer and more expensive proton therapy. And IMRT is better than conventional radiation therapy for reducing side effects and [...]

The cancer products portfolio that DARA BioSciences (NASDAQ:DARA) has been building by acquisition now has more than $9 million in fresh capital to help bring those products to market.The pharmaceutical company has completed a securities offering of preferred stock and warrants, according to securities filings. Raleigh, North Carolina-based DARA sold 10,250 shares of preferred stock, [...]

A company developing a new generation of low-toxicity kinase inhibitors for treating cancer has raised almost half of the $3.5 million it’s targeting in the midst of a phase 1 clinical trial.TyroGeneX is developing a targeted small molecule drug for solid tumors that it says could overcome the toxicity limitations and dosing holiday requirements of [...]

GlaxoSmithKline (NYSE:GSK) is working with a Japanese biotechnology company to see if that company’s technology can find potential new cancer treatments.GSK’s agreement with Tokyo-based Chiome Bioscience calls for the companies to first conduct a pilot study using Chiome’s proprietary technology. Chiome’s proprietary platform technology can generate antibodies. Under the agreement, GSK and Chiome will generate [...]

A novel targeted cancer therapy may have a place in the multibillion-dollar cancer therapeutics market if it delivers positive results in an ongoing phase 1 clinical trial and attracts enough investor interest.Using nucleic acid-based DNA-interference technology, ProNAi Therapeutics has created a class of therapies to treat cancer and other complex genetic diseases. Its most advanced [...]

Replacing the painful biopsy process with an instrument system and reagent kit that could detect cancer cells in the blood before they metastasize is the goal of a touted startup hoping to raise money this year.With its microfluidic chip to detect, separate and capture circulating cancer cells from peripheral whole blood, DeNovo Sciences hopes to [...]

The Center for Health Transformation filed for bankruptcy Wednesday in Atlanta, estimating it owes from $1 million to $10 million but has only as much as $100,000 in assets. Newt Gingrich was the chief fundraiser for the group that he started eight years ago, but resigned his post when he decided to run for president.AVI [...]